Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M593Revenue $M45.2Net Margin (%)8.1Altman Z-Score6.9
Enterprise Value $M485EPS $0.0Operating Margin %5.7Piotroski F-Score7
P/E(ttm)567Beneish M-Score0.6Pre-tax Margin (%)5.8Higher ROA y-yY
Price/Book5.110-y EBITDA Growth Rate %--Quick Ratio20.6Cash flow > EarningsY
Price/Sales13.95-y EBITDA Growth Rate %--Current Ratio20.6Lower Leverage y-yY
Price/Free Cash Flow56.7y-y EBITDA Growth Rate %--ROA % (ttm)2.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)3.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M69.6ROIC % (ttm)19.5Gross Margin Increase y-yY

Gurus Latest Trades with PGNX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PGNXJulian Robertson 2014-09-30 Buy 1.8%$4.15 - $5.56
($4.99)
$ 8.5672%New holding1,290,055
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PGNX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ISRAEL ROBERT JExecutive Vice President, Medi 2015-06-11Sell2,000$6.8324.74view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-13Sell3,000$721.71view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-11Sell2,000$6.8324.74view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-03Sell5,000$6.4931.28view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-01-12Sell2,000$7.0620.68view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-12-11Sell3,000$7.0720.51view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-21Sell9,000$721.71view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-13Sell10,000$6.8324.74view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-11Sell5,000$6.5330.47view
Broadfin Healthcare Master Fun10% Owner 2014-07-21Buy1,625,436$4.685.22view

Quarterly/Annual Reports about PGNX:

News about PGNX:

Articles On GuruFocus.com
Tiger Management’s Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, Monsanto, Nov 14 2014 
Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street Nov 07 2014 
Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 26 2013 
Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 27 2013 
Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX Oct 01 2012 
5 Stocks That Dropped the Most Since Gurus Bought Them Sep 13 2012 
Dendreon Could Push Higher If New Drug Trials Succeed Apr 23 2012 
Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Dec 01 2010 
Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Nov 02 2010 

More From Other Websites
PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Aug 04 2015
Progenics Pharmaceuticals Announces Exclusive Worldwide Licensing Agreement With Johns Hopkins... Aug 04 2015
8:31 am Progenics Pharm enters into an exclusive worldwide licensing agreement, with Johns Hopkins... Aug 04 2015
Progenics Pharmaceuticals Announces Exclusive Worldwide Licensing Agreement With Johns Hopkins... Aug 04 2015
PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jul 28 2015
Trending Now: PGNX Jul 28 2015
Mid-Morning Market Update: Markets Rise; Ford Beats Q2 Estimates Jul 28 2015
Progenics Announces Breakthrough Therapy Designation for Azedra in Pheochromocytoma and... Jul 28 2015
Progenics Announces Breakthrough Therapy Designation for Azedra in Pheochromocytoma and... Jul 28 2015
Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape Jul 22 2015
Progenics Pharmaceuticals Sets Second Quarter Financial Results Call for August 6 Jul 21 2015
Progenics Pharmaceuticals Sets Second Quarter Financial Results Call for August 6 Jul 21 2015
Moving Average Crossover Alert: Progenics Pharmaceuticals (PGNX) - Tale of the Tape Jul 09 2015
Is Progenics Pharmaceuticals (PGNX) Stock a Solid Choice Right Now? - Tale of the Tape Jul 09 2015
Progenics Pharmaceuticals Announces Plans to Move Forward With 1404 Phase 3 Trial Jul 07 2015
PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 07 2015
Progenics Pharmaceuticals Announces Plans to Move Forward With 1404 Phase 3 Trial Jul 07 2015
PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Jul 02 2015
Needham Is Bullish On Progenics Pharmaceuticals Jun 25 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK